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Background: The leaf of Zehneria scabra is traditionally used for the management of diarrhea in Ethiopia. Its use,
however, has not been scientifically validated for safety and efficacy. The aim of this study was to investigate
antidiarrheal and antisecretory effects of hydroalcolic leaf extract of Z. scabra in mice models.
Methods: For each of antidiarrheal, gastrointestinal motility and antisecretory activity study Swiss albino mice were
divided in to five groups. Group I was treated as control group and received 10 ml/kg of 2% Tween-80 orally; Group
II served as a positive control and took standard drug in each of the experiments orally; Group III, IV and V were test
groups which received the methanolic extract orally at 100, 200 and 400 mg/kg, respectively. Depending on the
model total weight of fecal output, total weight of wet feces, total number of fecal output, number of wet faeces,
length of intestinal transit and intestinal weight were collected. Finally, data were analyzed using one-way ANOVA
followed by Tukey’s post test.
Result: In castor oil induced diarrhea model, the extract dose produced a significant reduction in mean stool score
(1.94 ± 0.102) at 200 mg/kg. Moreover, the 100, 200, and 400 mg/kg doses inhibited stool frequency by 40, 45 and
55%, respectively. All test doses of extract and loperamide (3mg/kg) reduced fecal fluid content significantly
(p<0.01). The 100 mg/kg dose of extract produced 25.74% reduction of fluid content (p<0.001) while both 200 and
400 mg/kg showed 29.70 % (p<0.001) compared to negative control group.
Conclusion: The extract of Zehineria scabra showed antidiarrheal and antisecretory activity in mice model.
Moreover, the extract found to be safe at dose of 2000mg/kg in mice model. The findings suggest the validity of
the acclaimed effect of Zehineria scabra as antidiarrheal agent in Ethiopian traditional herbal medicine.
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Diarrhea is the passage of abnormal liquid or unformed
stool at an increased frequency. Infectious agents, certain
medications, plant and animal toxins, gastro-intestinal dis-
orders, and substances that increase gastrointestinal tract
secretions may cause it. It can also be caused by the inges-
tion of poorly absorbable materials, or inflammatory and
dysmotility problems of the gastro-intestinal tract [1-3].
Diarrheal diseases are one of the leading causes of
morbidity and mortality in developing countries and are* Correspondence: mail2wondm@gmail.com
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There are a number of epidemiological and experimental
evidences worldwide related to acute diarrheal disease,
which is one of the principal causes of death in the infants
[4]. Around 2.5 million children die each year worldwide
and 80% of which are reported in developing countries.
Diarrhea is most common in crowded living conditions
coupled with poor hygiene and malnutrition [5].
Although currently used drugs are important in the
management of diarrhea, they still are linked with adverse
effects and contraindications. For instance, racecadotril
and loperamide are used to treat secretary diarrhea but
they produce bronchospasm, vomiting and fever. More-
over, some are contraindicated in children below 6 yearsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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antibiotics used do have valuable importance to fight
this condition; however, drug resistance is another issue
to think about [6].
Despite immense technological advancement in modern
medicine, many people in the developing countries still
rely on healing practices and medicinal plants for their
health care needs. Moreover, to combat the problem of
diarrhea in developing countries, the World health
organization (WHO) has constituted diarrhea control
program aimed at a holistic approach to include all as-
pects of traditional medical practices, evaluation of health
education and preventive approaches [7]. A range of medi-
cinal plants with antidiarrheal properties has been widely
used by the traditional healers; however, the effectiveness
of many of these anti-diarrheal traditional medicines has
not been scientifically evaluated [8].
Traditional medicine practice has been documented in
Ethiopia for treatment of various ailments. Including
diarrhea for which by various plants has been used.
Zehneria scabra (Linn.f.) Sond. (Cucurbitacea) (vernacu-
lar name - ‘hareg ressa’) is one of the commonly used
medicinal plants in Ethiopian traditional medicine prac-
tices. Being a climbing or trailing herb, it can go up to
10 m in length. Stems become woody with corky-ridged
bark as they grow old. And it has ovate, broadly ovate or
pentagonal leaves. Traditionally in Ethiopia the flowers
of the plant has reportedly been used for topical treat-
ment of alopecia, wound and eczema along with other
herbals mixed together [9]. Additionally, the leaves [10],
fruit, and flower have been used for the treatment of ab-
dominal colic in decoction of water and taken orally
[11]. The traditional use of the leaves of this plant for
the treatment of diarrhea is also reported in rural central
Ethiopia and Burundi besides its use for skin reaction
[11]. Scientific works to testify to any of the claims are
almost non-existent except a few studies that conducted
antimicrobial activity test for the various extracts of the
dried, powdered leaves of Z. scabra. The results were
promising with the aqueous and methanolic extracts
exhibiting interesting inhibitory activity against S. aureus,
P. aeruginosa, E. coli and C. albicans [12,13]. Related to
phytochemical studies, NMR analysis of the ethyl acet-
ate root extract of the plant reported the presence of
gypenoside group, like many other Cucurbitacea family
members [14].
It is necessary to establish scientific evidences for
therapeutic use of such traditional medicinal plants, as
it may potentially be useful source of new effective
therapies in drug development process. Hence, this
study aimed at evaluating the traditional claim of anti-
diarrheal and antisecretory effect of methanolic leaf ex-
tract of Zehneria scabra and its acute toxicity in mice
model.Method
Drugs and chemicals
Methanol (RANKEM, India), Tween-80 (Sigma-Aldrich,
UK), Activated Charcoal (Lab. Reagent, India), Castor
Oil and loperamide were obtained from a local retail
outlet in Addis Ababa. Atropine Sulfate (AdvaCare,
USA), Hydrochloric Acid (BDH Ltd, England) Chloroform
(ACS, Merck), Sulfuric Acid (Farm Italia Carrloerba, Italy),
Ammonia (Merck Millipore, India), Acetic Anhydride
(Techno Pharmchem, India), Ferric Chloride (Fisher,
USA), Potassium Ferrocyanide (BDH Ltd, England),
Lead Acetate (BDH Ltd, England), and Ethyl Acetate
(ACS, Merck).
Plant material
The leaves of Zehneria scabra were collected from
Debre Tabor and surrounding area. Taxonomic identifi-
cations were then established by the Department of Biol-
ogy, National Herbarium, Addis Ababa University. A
voucher specimen was also kept there (Voucher sample
number WT/03).
Experimental animals
Healthy male Swiss albino mice, weighing between 20-
30g, were obtained from animal house of Pharmacology
department, University of Gondar. The animals were
housed in a polyethylene glycol cage (5 to 8 animals per
cage) and acclimatized, for a minimum of 5 days prior to
pharmacological studies. The animals were maintained
under standard condition of relative humidity (44-56%),
temperature (25 ± 2°C) and 12/12 h light–dark cycle
[15,16] and allowed free access to pellets and tap water.
Extraction procedure
The leaves of Zehneria scabra were collected and thor-
oughly washed with distilled water to remove dirt and soil.
The plant material was air-dried at room temperature and
pulverized into a dry powder. Then, 100 g of this material
was macerated with 500 ml initially and then the residue
was macerated with 400 ml and 300 ml of 80% methanol,
successively. The respective extract was filtered using
gauze and Whatman No-1 filter paper, and dried under re-
duced pressure, at temperature below 45°C in oven. The
percentage yield of the process was 17.5% (w/w). The ex-
tract material was kept in an air-tight container and stored
at 4°C until needed. The extract was semisolid at room
temperature and solidified at storage in a refrigerator.
When re-exposed to room temperature, however, the ex-
tract turned in to semisolid.
Preliminary phytochemical screening test
The crude extract was screened for the presence or ab-
sence of secondary metabolites such as alkaloids, steroidal
compounds, phenolic compounds, saponins, tannins and
Tadesse et al. BMC Complementary and Alternative Medicine 2014, 14:460 Page 3 of 8
http://www.biomedcentral.com/1472-6882/14/460anthraquinones using standard procedures by coloring
and precipitation assays using standard procedures as de-
scribed elsewhere [17,18].
Acute toxicity test
Acute toxicity test was done based on the limit test
recommendations of OECD 425 Guideline [16]. First,
female Swiss albino mouse was fasted for 4 h and then
loaded with 2000 mg/kg of the extract, orally. The mouse
was then observed for physical or behavioral changes
within 24 h strictly, with special attention during the first
4 h. Based on the results found from the first mouse,
other four female mice were recruited and fasted for 4
h. Then, the animals were administered a single dose of
2000 mg/kg followed by similar strict observation. Such
observation was continued for further 14 days for any
signs of toxicity.
Grouping and dosing of animals
The animals were randomly assigned to different groups-
as negative control group, treatment groups for different
doses of extracts of Zehneria scabra, and positive control
group. Group I was negative control and was given a ve-
hicle, (2% (v/v) Tween-80 in water). Group II (positive
control group) was given standard drug, loperamide (3
mg/kg, orally) in both castor oil induced antidiahreal test
and misoprostol induced antisecretory test and atropine
sulfate (0.1 mg/kg, i.p.) for gastrointestinal motility test by
charcoal meal. Group III to V (test groups) were given the
extract of Zehneria scabra at doses of 100 (ZS100), 200
(ZS200) and 400 (ZS400) mg/kg, respectively. Plant ex-
tracts and the standard drug, loperamide were dissolved
with distilled water, were administered orally and volume
administered was 10 ml/kg for all animals.
As per OECD [16] guideline, after the safety evaluation
of the plant, 1/10th of the maximum dose (2000 mg/kg)
was considered as a middle dose, half and double of the
middle dose were taken as the low and the high doses,
respectively. The test doses were prepared freshly on the
day of the experiment. Animals were treated with vehicle
or treatment 1 h before subjecting to the different tests.
Anti-diarrhea activity tests
Antidiarrhea activity on Castor oil-induced diarrhea
The method described by Franca 2008 [19] was followed
for this study. The animals were screened initially by giv-
ing 0.5 ml of castor oil and only those showing diarrhea
were selected for the final experiment. Each animal was
placed in individual cage, the floor of which was lined
with blotting paper and every hour the floor lining was
changed. Diarrhea was induced by oral administration of
0.5 ml castor oil to each mouse, 30 min before the above
treatments. Every hour, total weight of faecal output,
total weight of wet faeces, total number of faecal output,and number of wet faeces were recorded. A numerical
score based on stool consistency was assigned as follows:
normal stool = 1, semi-solid stool = 2 and watery stool =





Mean Number of wet
defecation control – testð Þ
Mean wet defecation of control
 100
The in vivo antidiarrheal index (ADI in vivo) was then
expressed according to the formula [21]:
ADIin vivo ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
DDT  GMT  NFSð Þ3
p
Where DDT is the delay in defecation time or diarrheal
onset (as % of control), GMT is the Gasrointesitinal mo-
tility by charcoal travel reduction (as % of control), and
NFS is the reduction in the number (frequency) of stools
(as % of control).
Gastrointestinal motility test by charcoal meal
After the grouping, each animal was loaded with 1 ml of
charcoal meal (3% deactivated charcoal in normal saline)
orally. After 30 min of respective treatment of each
group, the animals were sacrificed and the movement of
charcoal from pylorus to cecum was measured. The
charcoal movement was expressed in terms of percent-
age [22]. The percentage of inhibition of gastrointestinal
motility was determined by using the following equation:




The effect of the hydroalcoholic extract on fluid secre-
tion in intestine, which was induced by misoprostol at
20 μg/kg, was studied using mouse model. Mice were
fasted for 24 h before induction by misoprostol. 1h later
each group was then treated just as stated above in the
grouping and dosing of animals. Mice were then sacri-
ficed after 24 h and fluid accumulation ratio (the weight
of intestine to the rest of the body weight of mouse) was
recorded and the antisecretory activity was expressed in
percentage of inhibition [23].
% Inhibition of intestinal fluid accumulation ratio
¼ Ratio of test drug – Ratio of control
Ratio of Control
 100
In addition to this, the weight of wet stool and dry stool
(after 24 hr of defecation) were used to calculate the fluid
content in the stool and the difference between wet stool
and dry stool was recorded as stool fluid content.
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All data were expressed in appropriate data presentation
methods. Statistical analysis was carried out using one
way ANOVA followed by Tukey’s post hoc tests. The re-
sults were considered significant at p-value less than
0.05. For data processing and analysis SPSS statistical
software Version 20.0 was used.Ethical clearance
All procedures were complied with The Guide for the
Care and Use of Laboratory Animals [15] and OECD-
guideline-425 for acute toxicity [16]. The procedures
were approved by the Institutional Review Board of the
college of medical and health sciences, University of
Gondar and ethical clearance was obtained from the re-
search and publication office of the University (Ref. No.
CMHS-RPO/045/2013).Results
Preliminary phytochemical screening
The leaves of Z. scabra crude extract revealed the pres-
ence of various secondary metabolites based on prelim-
inary phytochemical screening test (Table 1). Among the
detected in the crude extract were tannins, saponins, an-
thraquinones, O-anthraquinones and phenols. On the
other hand, alkaloids and steroidal compounds were not
detected.Acute toxicity test
None of the animals showed behavioral, neurological or
physical changes characterized by symptoms such as re-
duced motor activity, restlessness, convulsions, coma,
diarrhea and lacrimation at the limit dose of 2000mg/kg
of the hydroalcoholic extract of Z. scabra during the ob-
servation period. In addition, no mortality was observed at
the test dose. Thus, the median lethal dose (LD50) of the
plant extract was found to be greater than 2000 mg/kg.Table 1 Phytochemical screening results of 80%










+: present, −: absent.The effect of Z. scabra extract on castor oil-induced
diarrhea in mice
The effect of the extract on the mean stool score and
number of wet feces is shown in Table 2. After 30 min
of the administration of castor oil, all the animals of the
negative control group (2% TW-80 treated) were appar-
ently diarrheic with a mean stool score of 2.68 ± 0.05
out of 3 scale stool score. Z. scabra extract at doses 100
mg/kg (p<0.05), 200 mg/kg (p<0.001) and 400 mg/kg
(p<0.01) significantly reduced the mean stool score and
the number of wet feces (p<0.001 for all doses) com-
pared to the negative control. Whilst loperamide signi-
ficantly decreased mean stool score and number of wet
feces compared to controls (p<0.001), no statistically sig-
nificant difference was noted when compared with the
other doses of the extract. It is of note that maximum
reduction was achieved still with loperamide (84.5%).
Moreover, treatment with Z.scabra produced a similar
pattern of change in number of defecation as depicted in
Table 3. Accordingly, a significant reduction in the num-
ber of defecations over four hours and the total number of
defecation was observed with all the test doses of the ex-
tract compared with the vehicle treated group. All test
doses demonstrated significant reduction in number of
defecation starting from the 2nd hour through the fourth
hour with percent inhibition of defecation 40, 45 and 55%
for 100, 200, and 400 mg/kg doses, respectively. However,
no apparent change was noted among the different doses
of the extract. The standard drug also showed a marked
reduction in number of defecation by about 65% com-
pared to vehicle treated group, which was by far the high-
est of all. However, once again no detectable changes were
noted when compared to all doses of the extract.
Stool fluid content is calculated as the difference of
the weight of wet stool (fresh) to that of the dried (mea-
sured after 24 h of defecation). As demonstrated in the
Table 4, treatment with 100 mg/kg and 200 mg/kg of
the extract did not produce significant decrease in stool
fluid content in the 1 h, 2 h and 4h compared to nega-
tive control. By contrast, 400 mg/kg of the extract did
show significant reduction (p<0.05) in the stool fluid
content by 0.05 ± 0.02 at 2 h. At the 3 h, all doses of the
extract and the positive control loperamide (3 mg/kg)
treated groups demonstrated a significant difference of
fluid content with 0.00 ± 0.00 (p<0.001), 0.09 ± 0.03
(p<0.01), 0.04 ± 0.02 (p<0.001) and 0.05 ± 0.02 g
(p<0.001) compared to that of 0.29 ± 0.08 g of the negative
control group. However, there was no significant differ-
ence in stool fluid content at the 4 h among the groups.
The effect of Z. scabra extract on interstitial motility in mice
The effect of Z. scabra extract on the intestinal transit is
depicted in Table 5. All doses of the extract failed to
produce significant alteration in the % intestinal motility
Table 2 The effect of Z. scabra extract on stool score scale in castor oil- induced diarrhea in mice
Group Onset of diarrhea Mean stool score Number of wet feces % Inhibition of diarrhea
2%TW-80 66.4±3.06 2.68 ± 0.05a 19.4 ± 2.44a -
Lop3 180.5±15.45 1.49 ± 0.093*** 3 ± 0.89*** 84.5
ZS100 100.33±8.41 2.34 ± 0.098*a 9.3 ± 1.20***b 52.1
ZS200 118.33±7.34 1.94 ± 0.102***b 7 ± 0.85*** 63.9
ZS400 140.00±16.48 2.26 ± 0.119**a 6.5 ± 0.81*** 66.5
Values are mean ± S.E (n=5) ***p<0.001 values compared with the negative control; **p<0.01 values compared with the negative control, *p<0.05 values
compared with the negative control. ap<0.001 values compared with the positive control; bp<0.01 values compared with the positive control.
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(2% Tween-80 solution) resulted in 90.6 ± 9.2% intestinal
motility by the marker-charcoal meal. The 100, 200 and
400 mg/kg oral dose of the extract exhibited 86.9 ± 8.4,
86.1 ± 5.9% and 78.0 ± 9.4% intestinal motility, respect-
ively (Table 5). However, the standard drug, atropine dem-
onstrated a significant inhibition in intestinal motility.
The effect of Z. scabra extract on intestinal fluid secretion
by weight ratio
As demonstrated in Table 6, all test doses of the extract
significantly reduced the intestinal weight ratio in dose
dependent manner. The 100 mg/kg oral dose of the ex-
tract produced 25.74% inhibition of weight of intestinal
content (p<0.001) relative to 2% TW-80 treated negative
control group. Moreover, both the 200 and 400 mg/kg
treated groups showed 29.70% inhibition of intestinal
weight ratio (p<0.001) relative to the negative control
group. In comparison to loperamide (3 mg/kg) treated
group, all tested doses of the extract depicted superior per-
centage of reduction in weight of intestinal ratio.
In vivo antidiarraheal index
Results for the in vivo antidiarheal index were 17.33,
21.31 and 34.25 at the dose of 100, 200 and 400 mg/kg
oral doses of the plant extract, while loperamide gave a
maximum index of 74.33.
Discussion
Several studies have validated the use of antidiarrheal
medicinal plants by investigating the biological activityTable 3 The effect of Z. scabra extract frequency of defecatio
Group Number of deifications in specific time
1hr 2hr 3hr
2%TW-80 4.6 ± 2.86 9.4 ± 1.12a 4.2 ± 0.8a
Lop3 5.2 ± 1.14 1.8 ± 0.70*** 0 ± 0.00*
ZS100 4.5 ± 0.72 4.2 ± 1.01** 2 ± 0.37*
ZS200 6.3 ± 0.615 2.7 ± 0.42*** 1.7 ± 0.50
ZS400 5.7 ± 1.33 1.7 ± 0.21*** 1.2 ± 0.40
Values are mean number of defecations ± S.E (n=5), *p< 0.05 compared with the n
compared with the negative control. ap<0.001 values compared with the positive cof extracts of such plants, which have antispasmodic
effects, delay intestinal transit, suppress gut motility,
stimulate water adsorption, or reduce the intraluminal
fluid accumulation [23]. The leaves of Z. scabra have
been used for its antidiahreal effect in Ethiopian folk
medicine without any scientific validation for its safety
and efficacy [24,25]. However, it is evidenced to have
antimicrobial activity against E.coli, S.auerus, P.auerogi-
nosa and C. albicans [12,13]. The present study was
conducted to validate antidiarrheal efficacy of Z. scabra
extract in the different experimental models of diarrhea.
In the present study the methanolic extract of Z. scabra
have showed antidiarrheal activity in different animal
models.
Despite the multiplicity of etiologies of diarrhea, litera-
tures state that there are four major pathophysiologies that
lead to diarrhea. These include increased luminal osmo-
larity (osmotic diarrhea), increased electrolytes secretion
(secretory diarrhea), decreased electrolytes absorption,
and deranged intestinal motility causing a decreased tran-
sit time [26]. As an intervention of diarrhea, many anti-
diarrheal agents elicit effects by reducing the gastrointes-
tinal motility and/or the secretions [23].
In contrast, laxatives and diarrhea causing agents en-
hance gastrointestinal motility and/or secretions. For in-
stance, castor oil; which is used as an inducer of diarrhea
in this study, is known for its laxative effects because of
the active principle, retinoic acid. The active principle of
castor oil is known to change the electrolyte permeability
of the intestinal membrane and through elevated prosta-





1.8 ± 0.49b 20 ± 2.43a -
** 0 ± 0.00* 7 ± 1.57*** 65
b 1.5 ± 0.56b 12 ± 0.95** 40
** 1 ± 0.31 11 ± 0.43** 45
** 0.5 ± 0.22 9 ± 1.53*** 55
egative control, **p< 0.01 compared with the negative control, ***p< 0.001
ontrol; bp<0.01 values compared with the positive control.
Table 4 The effect of Z. scabra on weight composition of
wet and dried stool in castor induced-diarrhea in mice
Group Stool fluid content in Weight (g)
1hr 2hr 3hr 4hr
2%TW-80 0.18 ± 0.12 0.50 ± 0.04 0.29 ± 0.08)a 0.04 ± 0.03
Lop3 0.07 ± 0.09 0.36 ± 0.18 0.00 ± 0.00*** 0.01 ± 0.01
ZS100 0.26 ± 0.10 0.28 ± 0.05 0.09 ± 0.03** 0.04 ± 0.02
ZS200 0.40 ± 0.09 0.18 ± 0.07 0.04 ± 0.02*** 0.07 ± 0.04
ZS400 0.42 ± 0.11 0.05 ± 0.02* 0.05 ± 0.02*** 0.01 ± 0.01
Values are mean weight of stool ± S.E. (n=5), *p< 0.05 compared with the
negative control, **p<0.01 compared with the negative control, ***p<0.001
compared with the negative control. ap<0.001 values compared with the
postive control.
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Because of this, castor oil was used to induce diarrhea in
the experimental animals of this study. Different re-
searches have shown that castor oil causes diarrhea 1–2 h
just after administration of 0.1-0.3 ml for mice [29]. In our
experiment diarrhea response was seen within 1 h in most
of the experimental subjects because of the high dose of
castor oil (0.5 ml/mice). Only those mice that showed the
diarrheal response were selected for the experiment, to
evaluate the effects of Z. scabra leaf extract.
The hydroalcolic extract of Z. scabra (100–400 mg/kg,
p.o.) significantly (p <0.001) reduced the fecal output
produced by castor oil at each hour interval and, of
course, in the overall 4h interval. At doses of 100–400
mg/kg (p.o.), the plant extract significantly (p < 0.001)
and dose dependently delayed the onset of diarrhea in-
duced by castor oil when compared with the untreated
controls. Z. scabra (200 mg/kg, p.o.) reduced the number
of fecal episodes by 45% while the dose of 400 mg/kg
(p.o.) significantly (p < 0.001) reduced the number of
defecation by 55%. However, the percent inhibition by
the 100 mg/kg was lower than the 200 and 400 mg/
kg, indicating higher dose of the crude extract do have
a much better antidiarrheal effect. This might be be-
cause it is a sub-threshold (sub-effective) dose. This
implies that a relatively high dose of the extract is
needed to produce an antidiarrheal. This is in line
with other reports of other species of plants in which
extracts of plants shown to exert antidiarrheal effect
at higher doses [17].Table 5 The effect of Z. scabra extract on intestinal transit in
Group Total length of intestine (cm) Distance travelled by cha
2%TW-80 59.2 ± 1.48) 53.7 ± 6.41a
Atropine 57.1 ± 2.86 0 ± 0.0
ZS100 56.6 ± 5.86 49.1 ± 6.0a
ZS200 59.9 ± 4.793 51.6 ± 2.9a
ZS400 55.8 ± 6.80 43.8 ± 9.8a
Values are mean length of intestine ± S.E (n=5). a p<0.001 values compared with thSimilarly, the extract demonstrated a significant reduc-
tion of mean stool score that indicated change of stool
consistency from watery to solid stool. At the same time,
the number of wet defecations decreased pointing that the
extract demonstrated antidiarrheal effect. 200 and 400
mg/kg doses of the extract were superior in reducing
mean stool score and number of wet stools, respectively.
Meanwhile, the standard drug showed a marked re-
duction in both fecal outputs produced by castor oil and
mean stool score by about 65% and 84%, respectively.
This was by far the highest of all treatment doses of the
extract. This can be attributed to the fact that lopera-
mide exerts its antidiarrheal activity by different mecha-
nisms like regulating the gastrointestinal tract, slowing
down motility in the intestine, reducing colon flow rates
and consequently any effect on colonic motility [30].
Clinically, diarrhea may result from disturbed bowel
function, in which case there is impaired intestinal
absorption, excessive intestinal secretion of water and
electrolytes, and rapid bowel transit [31]. The anti-
diarrheal index (ADI) is a measure of the combined ef-
fects of these different components of diarrhea such as
defecation frequency and onset of diarrheal stools, as
well as intestinal motility. The plant extract produced a
dose-dependent antidiarrheal index, although its great-
est effect was lower than that produced by loperamide,
the positive control.
The mean ratio of the weight of small intestine to rest
of the body of mice and stool fluid content were used to
determine the antisecretory activity of the extract. Consist-
ent with the findings of castor oil induced antidiarrheal
model, both parameters at all doses level of the extract
demonstrated significant antisecretory effect of the extract.
Therefore, it can be deduced that the extract possessed
comparable antisecretory activity to the standard drug. Al-
though the experimental antidiarrheal models are not a
complete predictors of clinical effectiveness, the findings
of this study clearly indicated the antidiarrheal potentials
of the plant extract.
The plant extract demonstrated significant reductions
of water contents, frequency of defecation and intestinal
fluid accumulation. On the other hand, gastrointestinal
motility test indicated its poor antimotility effect. The
overall findings show that the extract demonstrated amice using charcoal meal as a marker
rcoal (cm) % Intestinal transit % Inhibition relative to control
90.6 ± 9.2a -
0.0 ± 0.0 100
86.9 ± 8.4a 4.1
86.1 ± 5.9a 4.9
78.0 ± 9.4a 13.9
e positive control.
Table 6 The effect of Z. scabra extract on fluid secretion
in Misoprostol-induced mice using small intestine to the
body ratio








2%TW-80 2.09 ± 0.20 0.101 ± 0.012a -
Lop3 1.56 ± 0.28 0.076 ± 0.006* 24.75
ZS100 1.58 ± 0.26 0.075 ± 0.006* 25.74
ZS200 1.41 ± 0.19 0.071 ± 0.004* 29.70
ZS400 1.17 ± 0.37 0.071 ± 0.009* 29.70
Values are mean ± S.E (n=5), *p< 0.001 compared with the negative control.
ap<0.001 values compared with the positive control.
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http://www.biomedcentral.com/1472-6882/14/460comparable antidiarrheal and antisecretory effects. Al-
though the specific mechanisms of action of the extract
need to be explored, the antidiarrheal effect of the extract
could be related to inhibition of secretion, reducing intra-
luminal fluid accumulation or enhancing water absorption
but not delaying motility. It is widely reported that different
antidiarrheal agents exert their effect through different
mechanisms such as inhibiting secretion, decreasing motil-
ity, delaying intestinal transit, reducing intraluminal fluid
accumulation or by enhancing water adsorption [20,30,32].
Phytochemical screening of the plant extract revealed
the presence of tannins, phlabotanins, saponins, anthra-
quinone glycosides, O-anthraquinones. Previous studies
also reported the presence of tannins, unsaturated sterols/
triterpens and saponins [25]. Different literatures state that
components such as tannins, saponins, steroids, terpenes,
alkaloids and flavonoids are responsible for antidiarrheal
action of different plant extracts through different mecha-
nisms [33,34]. From which tannins and flavonoids are
suggested to be responsible for antidiarrheal activity by
increasing colonic water and electrolyte reabsorption
whereas the others are linked with inhibiting intestinal
motility. Tannins are best known to decrease the irrita-
bility of the bowel thereby reducing peristaltic index [35].
Therefore, antidiarrhea and antisecretory effects of Z.
scabra could be due to the presence of these phytoche-
micals. Besides, these effects were proved to be seen in the
different models of this study, which suggests that several
different constituents of the extract might be involved in
different mechanism of actions to produce antidiarrheal
and antisecretory effects.
Moreover, the acute toxicity study revealed the safety
of the extract at the limit dose of 2000mg/kg in mice. At
the test dose, mortality and delayed toxicity were not ob-
served in the 14 days post-treatment period. Likewise,
death was not recorded during the acute toxicity test.
Therefore, based on the findings, the LD50 value of the
80% methanolic extract of the plant is above 2000 mg/kg.
This indicates that the methanolic extract of Z. scabra is
better tolerated and safe after oral administered.Conclusion
The 80% methanolic leaf extract of Zehineria scabra
showed antidiarrheal activity in animal models. Thus,
the findings give the experimental basis to understand
the traditional claim of the plant. The 100, 200 and 400
mg/Kg doses of the plant extract demonstrated signifi-
cant antidiarrheal and antisecrtory effect and the higher
dose, 400 mg/kg, showed superior efficacy relative to the
other doses. However, the extract did not affect the
gastrointestinal motility at any of the study doses. The
plant extract was also found to have optimal safety mar-
gin based on the limit test at 2000 mg/kg dose level
acute toxicity test. Therefore, the plant is potentially use-
ful to develop plant based products after further studies
to identify the active principle and the mechanism of
action.
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